Dabur India Limited — Extract Exporter Profile
Indian Pharmaceutical Exporter · #1 for Extract · $1.1M export value · DGFT Verified
Dabur India Limited is the #1 Indian exporter of Extract with $1.1M in export value and 126 verified shipments. Dabur India Limited holds a 9.0% market share in Extract exports across 3 countries. The company exports 6 pharmaceutical products worth $1.9M across 1 therapeutic categories.
Dabur India Limited — Extract Export Profile: Buyers & Destinations
Where Does Dabur India Limited Export Extract?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED ARAB EMIRATES | $744.6K | 78 | 68.5% |
| NIGERIA | $182.4K | 23 | 16.8% |
| EGYPT | $159.4K | 25 | 14.7% |
Dabur India Limited exports Extract to 3 countries. The largest destination is UNITED ARAB EMIRATES accounting for 68.5% of Dabur India Limited's Extract shipments, followed by NIGERIA (16.8%) and EGYPT (14.7%). These destinations reflect Dabur India Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Extract from Dabur India Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| NATURELLE LLC | UNITED ARAB EMIRATES | $300.2K | 25 |
| AFRICAN CONSUMER CARE LIMITED | NIGERIA | $182.4K | 23 |
| NATURELLE LLC, | UNITED ARAB EMIRATES | $171.9K | 19 |
| NATURELLE LLC, EMIRATES LINK ROAD, | UNITED ARAB EMIRATES | $161.3K | 23 |
| DABUR EGYPT LIMITED | EGYPT | $159.4K | 25 |
| NATURELLE LLC EMIRATES LINK ROAD | UNITED ARAB EMIRATES | $61.2K | 9 |
| NATURELLE LLC,EMIRATES LINK ROAD, | UNITED ARAB EMIRATES | $49.9K | 2 |
Dabur India Limited supplies Extract to 7 buyers globally. The largest buyer is NATURELLE LLC (UNITED ARAB EMIRATES), followed by AFRICAN CONSUMER CARE LIMITED (NIGERIA) and NATURELLE LLC, (UNITED ARAB EMIRATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Extract Export Value and How Much Does Dabur India Limited Contribute?
India exported $6.6M worth of Extract through 2,147 shipments from 292 suppliers to 109 countries, serving 591 buyers globally. Dabur India Limited contributes $1.1M to this total, accounting for 9.0% of India's Extract exports. Dabur India Limited ships Extract to 3 countries through 7 buyers.
What Is the Average Shipment Value for Dabur India Limited's Extract Exports?
Dabur India Limited's average Extract shipment value is $8.6K per consignment, based on 126 shipments totaling $1.1M. The largest destination is UNITED ARAB EMIRATES (68.5% of Dabur India Limited's Extract exports).
How Does Dabur India Limited Compare to Other Indian Extract Exporters?
Dabur India Limited ranks #1 among 292 Indian Extract exporters with a 9.0% market share. The top 3 exporters are DABUR INDIA LIMITED ($1.1M), PANACEA BIOTEC PHARMA LIMITED ($723.4K), J B CHEMICALS AND PHARMACEUTICALS LIMITED ($625.8K). Dabur India Limited processed 126 shipments to 3 destination countries.
What Extract Formulations Does Dabur India Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| HERBAL EXTRACT - RTP 100 ( FOR EXPORT) | $234.4K | 21 |
| HERBAL EXTRACT DHTP -IBD | $180.4K | 21 |
| HERBAL EXTRACT- RTP 100 ( FOR EXPORT) | $125.0K | 7 |
| Herbal Extract - RTP 100 ( for Export) | $95.3K | 15 |
| HERBAL EXTRACT RTP 100 FOR EXPORT | $72.3K | 3 |
| Herbal Extract - RTP 100 for Export | $52.9K | 7 |
| HERBAL EXTRACT DHTP- IBD | $52.7K | 5 |
| HERBAL EXTRACT- RTP 100 (FOR EXPORT) | $51.7K | 4 |
| HERBAL EXTRACT - RTP 100 (FOR EXPORT)KGS | $43.1K | 3 |
| HERBAL EXTRACT - RTP 100 ( FOR EXPORT)KGS | $33.2K | 3 |
Dabur India Limited exports 25 distinct Extract formulations including tablets, capsules, syrups, and combination drugs. The top formulation is HERBAL EXTRACT - RTP 100 ( FOR EXPORT) with 21 shipments worth $234.4K.
Regulatory Requirements: Exporting Extract to Key Markets
What Dabur India Limited must comply with to export Extract to its top destination countries
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Dabur India Limited Compare to Nearest Extract Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | DABUR INDIA LIMITED ★ | $1.1M | 126 | 3 | $8.6K |
| 4 | PANACEA BIOTEC PHARMA LIMITED | $723.4K | 72 | 13 | $10.0K |
| 6 | J B CHEMICALS AND PHARMACEUTICALS LIMITED | $625.8K | 101 | 9 | $6.2K |
Dabur India Limited ranks #1 among 292 Indian Extract exporters. Average shipment value of $8.6K compared to the market average of $22.5K. The closest competitors by value are PANACEA BIOTEC PHARMA LIMITED and J B CHEMICALS AND PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Extract Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 385 | 17.9% |
| SAHAR AIR CARGO ACC (INBOM4) | 238 | 11.1% |
| Bombay Air | 128 | 6.0% |
| DELHI AIR | 124 | 5.8% |
| NHAVA SHEVA SEA (INNSA1) | 117 | 5.4% |
| DELHI AIR CARGO ACC (INDEL4) | 101 | 4.7% |
| Delhi Air | 82 | 3.8% |
| BANGALORE ICD (INWFD6) | 74 | 3.4% |
What Other Ayurvedic & Herbal Products Products Does Dabur India Limited Export?
Dabur India Limited also exports these ayurvedic & herbal products products. Each links to the detailed product page.
About Dabur India Limited
Dabur India Limited exports 6 products worth $1.9M. Beyond Extract, top products include Arishta, Churna, Asava, Bhasma, Gutika. View the complete Dabur India Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Extract — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Extract shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Dabur India Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 126 individual customs records matching Dabur India Limited exporting Extract, covering 25 formulations to 3 countries via 7 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 109+ countries, 591+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Extract Export Data from Dabur India Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Dabur India Limited's Extract exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Dabur India Limited
Full Company Profile →
6 products · $1.9M total trade · 1 categories
Extract Stats
Company Overview
Top Products by Dabur India Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Dabur India Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Extract. For current shipment-level data, contact TransData Nexus.